by Jordana Choucair | Jan 25, 2022 | Life Sciences
Johnson & Johnson said it expects its COVID-19 vaccine to bring in up to $3.5 billion this year, up from $2.39 billion in 2021. Still, contributions from its COVID-19 vaccine are a small percentage of the company’s total revenue because it sells its vaccine at a...
by Jordana Choucair | Jan 25, 2022 | Life Sciences
Pfizer Inc. and BioNTech SE said they are testing a version of their COVID-19 vaccine that targets the Omicron variant. Pfizer said results are expected in the first half of the year so that an Omicron-specific vaccine is available “should it be needed.”...
by Jordana Choucair | Jan 25, 2022 | Inequities and SDOH
Public Citizen is pushing Pfizer to make its COVID-19 antiviral pill more broadly available in lower-income countries to address the existing global inequities in access to vaccines and treatments. The advocacy group argued in a letter to Pfizer Chief Executive Albert...
by Jordana Choucair | Jan 25, 2022 | D.C. News
The Biden administration says it will not be enforcing the federal employee vaccine mandate amid ongoing litigation. The move comes after a Texas federal judge on Friday blocked the enforcement of the vaccine mandate for government employees. The judge called the...
by Jordana Choucair | Jan 24, 2022 | Public Health/Prevention
The Biden administration is expected to begin distributing 400 million free N95 masks to Americans this week. The masks will be made available at numerous local pharmacies and community health centers in an effort to combat the spread of the Omicron COVID-19 variant....
by Jordana Choucair | Jan 24, 2022 | Payers
A U.S. judge in Texas on Friday blocked the Biden administration from enforcing an executive order requiring federal employees to be vaccinated against COVID-19. Citing the Supreme Court opinion blocking the administration’s vaccine-or-testing mandate for private...
Recent Comments